№15 (348) / 2017

Z.A. Zalyalova (1, 2), I.F. Khafizova (1), Z.G. Khayatova (1)
PATHOPHYSIOLOGICAL BASES OF REHABILITATION IN CERVICAL DYSTONY
7-15
P.S. Laguta
ACETYLSALICYLIC ACID AND PRIMARY PREVENTION: NEW OPPORTUNITIES
16-23
O.D. Ostroumova (1, 2), A.I. Kochetkov (1), V.V. Vikentyev (1), E.E. Pavleyeva (1)
POSSIBILITIES OF AMLODIPINE/LISINOPRIL FIXED-DOSE COMBINATION IN REAL CLINICAL PRACTICE
24-30
N.P. Lyamina, E.S. Karpova
CARDIOVASCULAR SAFETY AND EFFICACY OF CELECOXIB: FOCUS ON TREATMENT AND CARDIOSOMATIC REHABILITATION
31-36
S.G. Kanorsky, A.F. Sereda
THE USE OF STATINES IN PATIENTS WITH ARTERIAL HYPERTENSION AND CHRONIC HEART FAILURE WITH PRESERVED LEFT VENTRICULAR EJECTION FRACTION
37-42
N.V. Korneyeva (1), S.L. Zharskiy (1), B.P. Shevtsov (2), A.O. Scherban (1), N.K. Fisenko (1)
COMPARATIVE ANALYSIS OF DEVELOPMENT AND COURSE OF MYOCARDIAL INFARCTION IN SMOKERS AND NON-SMOKERS
43-48
S.B. Fitilev, I.I. Shkrebneva, A.V. Vozzhaev, K.O. Tsukanova, D.A. Dimitrovа
TRENDS IN THE USE OF ANTI-ANGINAL PREPARATIONS IN THE SPECIALIZED OUTPATIENT CLINIC FOR THE FIVE-YEAR PERIOD
49-54
M.V. Ezhov, E.V. Sorokin
SAFETY AND EFFICACY OF LONG-TERM THERAPY WITH HIGH DOSES OF ATORVASTATIN
55-60
O.D. Ostroumova (1, 2), Т.М. Ostroumova (2), E.V. Borisova (3), V.A. Perepelov (2)
CEREBROPROTECTIVE EFFECTS OF FIXED-DOSE COMBINATION OF PERINDOPRIL ARGININE/INDAPAMIDE
61-67
V.Ya. Dzerve
ENERGY METABOLISM CORRECTOR MILDRONATE®: INTERRELATION OF MECHANISMS OF ACTION AND THERAPEUTIC EFFECTS
68-73
I.T. Murkamilov (1, 2), K.A. Aitbayev (3), V.V. Fomin (4), Z.R. Rayimzhanov (5), N.A. Redzhapova (6), F.A. Yusupov (6), Z.A. Aydarov (1)
SUPPRESSION OF PROGRESSION OF RENAL DYSFUNCTION AND CEREBROVASCULAR EVENTS: POTENTIALS OF ATORVASTATIN
74-82
V.D. Makarova (1), M.R. Egiyan (1), E.A. Orlov (1), I Sun Cher (2), V.A. Dadaeva (3), A.Yu. Os’kova (1), E.S. Akarachkova (4), A.S. Orlova (1), E.V. Silina (1)
IMPORTANCE OF INCREASING AWARENESS OF CHILDREN AND ADOLESCENTS ABOUT RISK FACTORS AND THE main SYMPTOMS OF THE STROKE
83-87

Бионика Медиа